Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis

Abstract

Background:

Single nucleotide polymorphisms (SNPs) near SOCS1 are associated with multiple sclerosis (MS), but the most important SNPs in the area and mechanisms by which they influence the disease are unknown.

Methods:

A haplotype-tagging association study was performed covering 60.5kbp around SOCS1, and the index SNP was validated in a total of 2292 individuals. mRNA expression of SOCS1 and nearby genes was measured in MS patients with different disease courses and healthy controls. SOCS1 protein expression was studied by flow cytometry in a separate cohort of patients and controls. Differentiation and maturation of monocyte-derived dendritic cells (moDCs) were also studied.

Results:

One SNP, rs423674, reached genome-wide significance. No genotype-specific mRNA expression differences were seen, but, by flow cytometry, significant interactions were observed between genotypes for rs423674 and disease activity (relapse or remission) in B cells and regulatory T cells. Furthermore, homozygotes for the risk allele (GG) showed higher levels of CD1a and CD86 than carriers of the protective allele (GT) in immature moDCs and a greater increase of HLA-DR+ cell percentage than GT heterozygotes upon maturation.

Conclusions:

rs423674, or its genetic proxies, may influence MS risk by modulating SOCS1 expression in a cell-specific manner and by influencing dendritic cell function.

Keywords

SOCS1 multiple sclerosis relapsing–remitting SNP expression

Get full access to this article

View all access options for this article.

References

Sawcer

Hellenthal

Pirinen

. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214–219.

Gandhi

McKay

Cox

. The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. Hum Mol Genet 2010; 19: 2134–2143.

Weissert

. The immune pathogenesis of multiple sclerosis. J Neuroimmune Pharmacol 2013; 8: 857–866.

Yoshimura

Suzuki

Sakaguchi

. SOCS, inflammation, and autoimmunity. Front Immunol 2012; 3: 1–9.

Swanberg

Lidman

Padyukov

. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 2005; 37: 486–494.

The International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357: 851–862.

Vandenbroeck

Alvarez

Swaminathan

. A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis. Genes Immun 2012; 13: 21–28.

Zuvich

McCauley

Oksenberg

. Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility. Hum Genet 2010; 127: 525–535.

Beecham

Patsopoulos

Xifara

. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013; 45: 1353–1360.

10.

Stark

Cross

. Differential expression of suppressors of cytokine signaling-1 and -3 and related cytokines in central nervous system during remitting versus non-remitting forms of experimental autoimmune encephalomyelitis. Int Immunol 2006; 18: 347–353.

11.

Berard

Kerr

Johnson

. Differential expression of SOCS1 in macrophages in relapsing–remitting and chronic EAE and its role in disease severity. Glia 2010; 58: 1816–1826.

12.

Poser

Paty

Scheinberg

. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227–231.

13.

McDonald

Compston

Edan

. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121–127.

14.

Schmittgen

Livak

. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 2008; 3: 1101–1108.

15.

Sallusto

Lanzavecchia

. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179: 1109–1118.

16.

Purcell

Neale

Todd-Brown

. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–575.

17.

Benjamini

Hochberg

. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995; 57: 289–300.

18.

Brunner

Domhof

Langer

. Nonparametric analysis of longitudinal data in factorial experiments. New York: Wiley, 2002.

19.

Noguchi

Gel

Brunner

. nparLD: An R software package for the nonparametric analysis of longitudinal data in factorial experiments. J Stat Softw 2012; 50: 1–23.

20.

Zuvich

Bush

McCauley

. Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: Independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complex. Hum Mol Genet 2011; 20: 3517–3524.

21.

Leikfoss

Mero

Dahle

. Multiple sclerosis-associated single-nucleotide polymorphisms in CLEC16A correlate with reduced SOCS1 and DEXI expression in the thymus. Genes Immun 2013; 14: 62–66.

22.

Nuyts

Lee

Bashir-Dar

. Dendritic cells in multiple sclerosis: Key players in the immunopathogenesis, key players for new cellular immunotherapies? Mult Scler 2013; 19: 995–1002.

23.

Bartz

Avalos

Baetz

. Involvement of suppressors of cytokine signaling in toll-like receptor-mediated block of dendritic cell differentiation. Blood 2006; 108: 4102–4108.

24.

Jackson

Mahdi

. Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling. J Immunol 2004; 172: 2307–2315.

25.

Kono

Urban

Horvath

. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice. J Exp Med 1988; 168: 213-227.

26.

Bielekova

Goodwin

Richert

. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand. Nat Med 2000; 6: 1167–1175.

27.

Vandenbroeck

Alvarez

Swaminathan

. A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis. Genes Immun 2012; 13: 21–28.

28.

Ramgolam

Sha

Marcus

. B cells as a therapeutic target for IFN-β in relapsing–remitting multiple sclerosis. J Immunol 2011; 186: 4518–4526.

29.

Tanaka

Ichiyama

Hashimoto

. Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-gamma on STAT3 and Smads. J Immunol 2008; 180: 3746–3756.

30.

Chong

Cornish

Darwiche

. Suppressor of cytokine signaling-1 is a critical regulator of interleukin-7-dependent CD8+ T cell differentiation. Immunity 2003; 18: 475–487.

31.

Raj

Rothamel

Mostafavi

. Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes. Science 2014; 344: 519–523.

32.

Takahashi

Yoshimura

. SOCS1 and regulation of regulatory T cells plasticity. J Immunol Res 2014; 2014: 1–8.

33.

Viglietta

Baecher-Allan

Weiner

. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199: 971–979.

34.

Huan

Culbertson

Spencer

. Decreased FOXP3 levels in multiple sclerosis patients. J Neurosci Res 2005; 81: 45–52.

35.

Venken

Hellings

Thewissen

. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing–remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 2008; 123: 79–89.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.17 MB

0.14 MB

0.02 MB

0.01 MB

0.08 MB